Viatris Healthcare B.V. Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. We have been included on number of award lists that demonstrate the impact we are making.

Position Title: Head of Market Access Australia and New Zealand
Location: Sydney

Position Overview

As Viatris continues expanding its portfolio of innovative and value-added medicines, we are seeking an experienced and strategic Head of Market Access to lead our Market Access efforts across Australia and New Zealand. This role plays a critical part in shaping and executing strategies for pricing, reimbursement, and market access across the product lifecycle—from early development through launch and post-launch optimization. The Head of Market Access will lead cross-functional coordination, engage with key national stakeholders (including PBAC, MSAC, PHARMAC, payers, and policy influencers), and ensure the value of Viatris' medicines is clearly communicated and supported with robust evidence. The role reports to both the Country Manager ANZ and with European and Global Market Access leadership.

Key Responsibilities

Strategic Leadership develop and lead integrated Market Access strategies for Australia and New Zealand across all therapeutic areas, with a focus on innovative and value-added medicines. Oversee and guide submissions to PBAC, MSAC, PHARMAC, and other pricing and reimbursement bodies, ensuring strategic alignment and compliance. Oversee price governance, shape pricing corridors, reimbursement conditions, and value frameworks in alignment with global and regional objectives.



Closely monitor and analyze competitor reimbursement activities to ensure Viatris remains competitively positioned, while upholding to both internal and external compliance with pricing regulations. Monitor and analyze market trends, policy changes and competitive landscape to inform access strategy development for Vitaris’ innovative assets. Provide strategic insights into payer value creation, reimbursement evidence needs and innovative contracting agreements.

Cross-Functional Collaboration collaborate with Medical Affairs, Regulatory, Commercial, Policy, Health Economics, and Global Pricing teams to ensure access readiness and evidence generation plans. Serve as the lead Market Access representative on local launch teams and product-specific initiatives. Adapt and localize global value dossiers, economic models, and HEOR materials to Australian and Current Zealand requirements.

Stakeholder Engagement develop and maintain strong relationships with HTA bodies (PBAC/MSAC), PHARMAC, private insurers, government agencies, and healthcare system influencers. Actively contribute to shaping the external environment through engagement with policy stakeholders and industry associations.

Required Qualifications

Advanced degree in life sciences, pharmacy, medicine, health economics, public health, or related field. Minimum of 8–10 years of experience in Market Access and Health Economics in Australia and/or New Zealand, including direct experience with PBAC/MSAC and PHARMAC submissions. Strong understanding of HEOR principles and their application in local reimbursement contexts. Support capability building in access, pricing, and health economics across the affiliate and wider APAC region if applicable.



Demonstrated success in developing and executing Market Access strategies for innovative medicines. In-depth knowledge of local healthcare systems, reimbursement frameworks, and evolving policy trends.

Benefits

- Employee rewards and discount platform
- Annual wellness allowance
- Recognition programs
- Benefits for health and financial wellness
- Corporate deals with vendors including superannuation fund, health insurance and others
- Viatris Product loyalty program
- Free annual flu vaccination
- 2 days of paid volunteer leave per annum
- Additional paid parental leave
- Career and development planning for continuous growth and learning
- Retirement savings plans
- Annual leave loading, as well as paid additional bereavement leave

Culture

Viatris Australia is a certified Great Place To Work for 2025, and has been named in Forbes’ World’s Best Employers 2022 list. We have now received this recognition in each of our first two years – and for 2022, we are ranked in the top 10% of the 800 global employers who made the ranking. Viatris strives to create a positive, productive work environment where integrity, dignity and mutual respect for all is ingrained each and every one of us. Together, we are building an inclusive organisation where employees are welcome to bring their best, authentic selves to work every day.

Viatis is an Equal Opportunity Employer.

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance. We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.

#J-18808-Ljbffr

📌 Head of Market Access ANZ (New South Wales)
🏢 1100 Mylan Pharmaceuticals
📍 New South Wales